摘要
目的:观察青蒿醇提物对H22肝癌小鼠的体内抑瘤作用。方法:取H22肝癌细胞接种于小鼠右腋皮下,随机分为模型对照组、5-氟尿嘧啶组(5-FU)及青蒿醇提物125 mg/(kg.d)组、500 mg/(kg.d)组,5-FU组肌肉注射给药,其余各组灌胃给药。连续给药8 d后,剖瘤称取质量,计算抑瘤率;利用高效液相色谱仪测定青蒿醇提物中青蒿素含量。结果:与模型对照组比较,青蒿醇提物各剂量组均不同程度的抑制肿瘤生长(P<0.01),青蒿醇提物125 mg/(kg.d)组和青蒿醇提物500 mg/(kg.d)组的抑瘤率分别为54.6%、50.6%;本实验青蒿醇提物中青蒿素含量为0.02%,而在青蒿素抗H22小鼠肝癌试验中,青蒿素在剂量为10 mg/(kg.d)时,对H22小鼠肝癌已没有明显的抑制作用。结论:青蒿醇提物对肝癌有明显的抑制作用;除青蒿素以外,中药青蒿中可能存在其它的抗肿瘤成分。
Objective : To observe the inhibitory effect of Artemisia Ethanol Extract on tumor growth on murine transplanted hepatocarcinoma 22 (H:2) in vivo. Methods:Tumor inhibitory activities were tested in experimental tumor H22 mice. The tumor bearing mice were randomly divided into control group ,5-fluorouracil group (5-FU, 15 rag/( kg .d)) and Artemisia Ethanol Extract treatment groups (125 rag/( kg.d) group ,500 rag/( kg. d) group). These mice were given normal saline, or Artemisia Ethanol Extract different doses by gavage respectively once a day for 8 days, while 5-FU were given by intramuscular injection. Tumor growth state was observed and tumor inhibitory rate was calculated;To establish an HPLC method for the quantitative determination of the Artemisini in Artemisia Ethanol Extract. Resuhs:Artemisia Ethanol Extract treated groups with different doses could inhibit hepatocarcinoma 22( H22 ) growth (P 〈 0.01 ) ,the inhibitory rate 125 mg/( kg ~ d) group and 500 mg/( kg ~ d) group respectively was 54.6% ,50.6% ;In the experiment of Artemisinin on tumor growth on murine transplanted hepatocarcinoma 22 ( H2z ), It was showed that Artemisinin did not perform significant antitumor effects on hepatocarcinoma 22( H22 ) at the dose of 10 rag/( kg.d) ;The determination of the Artemisini in Artemisia Ethanol Extract was 0.02%. Conclusion:Artemisia Ethanol Extract can inhibit hepatocarcinoma growth;In addition to Anemisinin, other antitumor components may exist in Artemisia annua.
出处
《中医学报》
CAS
2011年第5期531-533,共3页
Acta Chinese Medicine
基金
国家中药材扶持项目(编号:广东/39)
关键词
青蒿醇提物
H22肝癌
抑瘤率
小鼠
artemisia ethanol extract
H22hepatocarcinoma
tumor inhibitory rate
mice